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Membrane adsorption of j32-microglobulin: Equilibrium and kinetic
characterization. Enhanced extracorporeal removal of j32-microglobulin
(j32m) may prevent the development of dialysis-related amyloidosis(DRA). One mechanism of f32rn removal is membrane adsorption.
Therefore, we fundamentally characterized /32m adsorption to the highly
permeable polyacrylonitrile (PAN) membrane. Porous and nonporous
PAN fragments were incubated in buffer containing 1I-2m. Over a
concentration range of 8 to 60 mg/liter, the equilibrium adsorption
isotherm was linear (r = 0.99) for porous PAN while the isotherm for
nonporous PAN suggested either multilayer binding or adsorption of
proteins with differing orientations. In kinetic analyses, the approach to
equilibrium versus (time)"2 was evaluated. For both porous and nonpo-
rous PAN, this relationship was linear (r = 0.99), consistent with a
diffusion-controlled process. Adsorption reversibility was assessed by
comparing the amount bound at varying residence times (0 to 4 hr) to the
amount remaining adsorbed after a subsequent incubation in buffer. The
fractions remaining bound at 60, 120, and 240 minutes (0.34 0.02, 0.36
0.06, and 0.44 0.03;mean SEM) were significantly greater (P C 0.05)
than the value at five minutes (0.23 0.01). This suggests membrane-
induced conformational changes in adsorbed f32m. This investigation
permits the comparison of 2m adsorptive properties of PAN to those of
other membrane-based and nonmembrane-based therapies designed to
prevent DRA.
Dialysis-related amyloidosis (DRA) remains a major source of
morbidity for patients treated with long-term hemodialysis [1—8].
The clinical manifestations of DRA, which include carpal tunnel
syndrome, cystic bone lesions, and arthropathies, are mediated by
the osteoarticular deposition of an amyloid protein [8]. The
precursor of this amyloid protein is the low-molecular weight
(LMW) protein 2-microglobulin (f32m) [9]. Multiple prior stud-
ies have demonstrated essentially no 132m is removed by cu-
prophane dialyzers, either by transmembrane removal or mem-
brane adsorption [10—12]. Conversely, renal replacement therapy
with membranes of higher permeability permits the elimination of
$2m in substantial amounts [10—19]. Two recent studies have
suggested that the use of high permeability membranes, rather
than cuprophane, lessens the likelihood of DRA development [20,
21]. Although treatment with highly permeable membranes does
not result in normalization of serum 2m concentrations, their
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ability to remove significant amounts of 132m may result in less
2m available for incorporation into amyloid.
Recent investigations have demonstrated that in addition to
transmembrane removal, adsorption is a mechanism by which
j32m [10—19] and other LMW proteins [22—24] are removed by
high permeability membranes. Adsorption accounts for a signifi-
cant percentage of the total 32m removal by hemodialyzers
containing these hydrophobic polymers. Adsorption is the sole
2m removal mechanism by some hemodialyzers composed of
polymethylmethacrylate (PMMA) membranes [13, 18] and is also
more significant than transmembrane removal for sulfonated
polyacrylonitrile (PAN) hemodialyzers [12, 13]. Nonmembrane-
based extracorporeal therapies utilizing adsorption specifically for
132m removal have also been reported recently [25, 26]. Unfortu-
nately, none of these studies has provided fundamental parame-
ters, such as equilibrium isotherm and kinetic data, that are
necessary for the rigorous analysis of any protein adsorption
process [27]. In the design of extracorporeal therapies with
maximized /32m removal capabilities, this basic information is
needed to assess and compare each treatment's adsorptive poten-
tial.
Therefore, the purpose of this investigation was to perform the
initial fundamental characterization of the adsorption of 132m to
hemodialysis membranes. Two potential benefits may arise from a
complete characterization of the adsorption process. First, these
studies may lead to extracorporeal therapies with enhanced j32m
removal capabilities that prevent the development of DRA. In
addition, these investigations should advance the understanding
of the manner in which plasma components, especially LMW
proteins, interact with highly porous membranes. The study was
conducted on the sulfonated PAN membrane, a prototypical high
permeability membrane with significant /32m adsorption capacity.
Methods
i32m radioiodination and characlerizalion
All experiments were single-component incubation studies in
which radiolabeled f32m was utilized as a tracer. Incubations
occurred at 37°C. Radioiodination with Na'25I (Amersham Co.,
Arlington Heights, Illinois, USA) of 2m (Sigma Chemical Co.,
St. Louis, Missouri, USA) was accomplished with lodogen (Pierce
Chemical Co., Rockford, Illinois, USA) by use of the following
procedure. Iodogen, dissolved in chloroform, was applied to the
surface of a 12 x 75 borosilicate glass tube by evaporation of the
chloroform with a stream of dry N2. To this Iodogen-coated tube
1140
Clark et al: Membrane adsorption of /32m 1141
was added 250 tg f32m dissolved in 250 p1 of phosphate-buffered
saline (PBS), pH 7.4. Na'251 (300 tCi) was added to the tube and
the iodination allowed to proceed for approximately 30 minutes.
The reaction was quenched by the addition of 20 il (1 tg) of
tyrosine (Sigma) dissolved in PBS. The reaction solution was
immediately transferred to a Sephadex G-25 column (Kabi Phar-
macia, Piscataway, New Jersey, USA) which had been previously
equilibrated with 0.1% bovine serum albumin (BSA, Sigma) in
PBS, pH 7.4. After addition of the reaction solution, the column
was eluted with PBS and serial effluent samples (0.75 ml) were
withdrawn.
The analysis of each effluent sample was as follows. A 5 p1
aliquot from each sample was added to 2.0 ml of PBS. From this
solution, two 100 p1 samples were obtained. One sample was used
for measurement of total radioactivity (radioiodinated protein
and free 1251). To the other 100 p1 sample was added 400 p1 1%
BSA and 500 p1 20% trichloroacetic acid (TCA, Sigma). The
resulting solution was put on ice for 15 minutes and then spun in
a microcentrifuge for five minutes. The pellet was washed with 500
p1 10% TCA and centrifuged again for five minutes. The radio-
activity was then measured in a gamma counter (Packard Instru-
ments, Downers Grove, Illinois, USA) and compared to the total
radioactivity from the first 100 p1 sample. Effluent samples
containing TCA-precipitable counts that were 94% of the total
counts were retained as the radioiodinated protein. The retained
effluent samples were pooled and the /32m concentration deter-
mined with an enzyme immunoassay (132-micro EIA, Kabi Phar-
macia Diagnostics, Uppsala, Sweden). For both unlabeled and
labeled 132m, sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE), as described by Laemmli [281, was per-
formed.
132,n adsorption studies
The adsorption of 132m to dialysis membranes composed of
PAN, a copolymer of acrylonitrile and sodium methallyl sulfonate
(AN69, CGH Inc., Lakewood, Colorado, USA), was studied.
Initial experiments were designed to ensure that the radioiodina-
tion process did not alter the adsorption characteristics of 1251
132m to dialysis membrane fragments. By use of the membrane
incubation procedure subsequently described in detail, competi-
tive adsorption studies were performed in which the proportion of
labeled and unlabeled 132m varied. In these experiments, 50 p1
aliquots of 132m (in PBS) solution were incubated for one hour
with 4 mm fragments (nominal surface area, 0.25 cm2) of PAN
membrane (vide infra). The proportion of the amount of 1251-f32m
to the total amount of /32m ranged from 0.2 to 1.0.
Binding curves (amount adsorbed vs. time) for j32m adsorbing
to PAN fragments were subsequently developed. A 4 mm PAN
fragment was cut from a flat sheet hemodialysis membrane by use
of a dermatologic curette (George Tiemann Co., Hauppauge,
New York, USA). The sample was washed three times with PBS
and allowed to air dry. The membrane was incubated in a 12 X 75
polypropylene tube containing 50 1d of /32m solution (25 or 50
mg/liter) for time periods ranging from 30 seconds to four hours.
The membrane was then transferred to a separate tube after first
rinsing with PBS five times to remove loosely adherent protein.
The membrane-associated radioactivity was quantitated for each
incubation time and the specific activity was used to calculate the
amount of bound f32m.
The adsorption isotherm curve for /32m adsorption to PAN was
generated in the following manner. A 4 mm membrane fragment
was incubated in 50 j.tl of 2m solution at an initial concentration
within the 8 to 60 mg/liter range. After a four hour incubation
period, the membrane was removed, washed five times with PBS,
and transferred to a separate tube for determination of mem-
brane-associated radioactivity. To the adsorbate remaining in the
original incubation tube, 1.0 ml of PBS was added, the tube
vortexed, and the contents transferred to a separate tube for
radioactivity measurement. The purpose of this step was to
remove any 2m loosely adherent to the original incubation
vessel. From the radioactivity present in this wash solution, the
specific activity was used to calculate the amount of f32m in the
original sample at equilibrium. Knowledge of the equilibrium
sample volume (50 p1) allowed determination of the f32m solution
concentration at equilibrium. Finally, the residual radioactivity of
the original incubation vessel was determined to account for
nonspecific binding.
Because the PAN pore surface area greatly exceeds the nominal
surface area, the adsorption of LMW proteins capable of pore
entry should occur predominantly in the pores. Unfortunately,
reliable estimates of the surface area of the PAN pore system
were not available for this study. Consequently, determination of
adsorbed surface concentrations (1kg/cm2) for porous PAN was
not possible. On the other hand, accurate calculation of adsorbed
surface concentrations was possible with a nonporous PAN prep-
aration used in this study because of its well defined adsorption
surface area. Therefore, binding and equilibrium isotherm curves
for f32m adsorption to a nonporous PAN preparation (Hospal
R&D mt., Lyon, France), prepared from the same polymer
solution used to manufacture the porous PAN, were also gener-
ated. Because the surface energies, as determined by the contact
angle method, and surface compositions, as determined by x-ray
photoelectron spectroscopy, of the porous and nonporous PAN
were essentially the same (personal communication, Hospal R&D
mt.), the f32m adsorptive features of the two preparations could be
compared directly.
132m desorption studies
The reversibility of 2m binding to porous PAN membranes
was also assessed. In these experiments, 4 mm fragments of
porous PAN were incubated in 50 p1 of 132m (25 mg/liter) for time
periods ranging from five minutes to four hours. For each
incubation time, a control membrane and test membrane were
studied concurrently. At the end of the pre-determined incubation
time, both the control and test membrane were removed and
washed five times with 1.0 ml of PBS. The test membrane was then
incubated for one hour in a separate tube containing 1.0 ml of
PBS. Following this incubation period, the test membrane was
washed five times with PBS. The radioactivity of both the control
and test membranes was then quantitated to determine the
amount of f32m bound.
Statistical methods
Comparisons were done with an unpaired Student's t-test in
which P < 0.05 was considered statistically significant. All mea-
surements were performed in duplicate and results are expressed
as mean SEM.
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Labeled 2m offered/
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Fig. 1. Amount of '251-f3.'n adsorbed by porous PAN versus amount ofl25j, offered in solutions containing varying proportions of labeled and
unlabeled protein. Both quantities are expressed in relation to the case in
which adsorption is from a solution containing only '251-/32m. A linear
relationship exists (r = 0.99). Values are mean saM; N = 2.
Fig. 2. Porous PAN binding curves of amount (32m adsorbed versus time for
initial solution concentrations of 25 (•) and 50 (N) mg/liter. Values are
mean SaM; N = 4 or 5.
Initial [f32m]
mg/liter
Amount J32m
offered ng
Amount f32m
bound ng
Equilibrium
j32m mg/liter
Fraction /32m
bound
8 400 31 2 3.5 0.4 0.12 0.01
10 500 42 4 4.3 0.4 0,13 0.02
15 750 101 6 10.4 0.2 0.15 0.01
25 1250 157 7 17.4 1.0 0.16 0.01
40 2000 277 25 27.3 0.4 0.16 0.02
50 2500 352 30 38,6 1.0 0.17 0.02
60 3000 481 28 42.9 0.8 0.18 0.01
Values are mean SEM.
N = 4 or 5.
a)
U)
E
WE
CU
-I x
CU
1.0
0.8
0.6
0.4
0.2
0.0
a)
0
U)
CU
E
4-.
0
E
500
400
300
200
100
00.0 0.2 0.4 0.6 0.8 1.0 0 100 200
Time, minutes
300
Table 1. Adsorption isotherm results
Results
Characterization of 1251 f3
In four separate J32m iodinations the mean 1251-/32m specific
activity was 1.18 X 106 cpm/j.g (range, 0.73 to 1.83 X 10 cpm/jg).
The mean ratio of unlabeled to labeled 132m in these experiments
was 12.4 (range, 3.8 to 17.6). SDS-PAGE analysis of both labeled
and unlabeled j32m revealed a single band at approximately 12
kDa in each case (data not shown).
Results of the competitive binding studies in which there were
varying proportions of labeled and unlabeled /32m appear in
Figure 1. The ratio of the amount of offered '25I-2m to the total
amount of offered f32m, the independent variable in these exper-
iments, ranged from 0.2 to 1.0. A linear relationship existed
between the amount of offered 'I-f32m and the amount of
1I-/32m bound. The latter value is also expressed as a ratio, that
being the amount of 1I-i32m bound to the amount bound from a
solution containing only labeled j32m. These results demonstrate
that the binding affinity of both the labeled and unlabeled j32m
were the same and suggest that the iodination process did not
alter the f32m adsorption characteristics.
f32m binding curves
Figure 2 demonstrates both the time and concentration depen-
dence of 132m adsorption to porous PAN fragments. Both curves
show there was an early rapid uptake of 132m by the membrane,
such that approximately 50% of the total amount bound was
adsorbed within the first 30 minutes, Each curve also exhibits an
initial plateau after the first 30 minutes, coincident with approx-
imately 50% protein deposition, followed by a second monotonic
rise and plateau at equilibrium. These findings suggest either
bilayer binding or a protein layer in which f32m is adsorbed in both
side-on (longest segment bound) and end-on (shortest segment
bound) orientations [29]. In addition, the amount adsorbed at 120
minutes for each curve was not statistically different from the
amount adsorbed at the two subsequent time points (P> 0.05).
Therefore, since the attainment of equilibrium occurred within
the first two hours of incubation, four hour incubation times were
employed in the subsequently described adsorption isotherm
experiments.
Equilibrium isotherm curves
The concentration dependence of 132m adsorption to both
porous and nonporous PAN was evaluated by isotherm experi-
ments. In Table 1, results of these experiments for porous PAN
are shown. The following adsorption parameters for each initial
f32m solution concentration are reported: amount of 2m initially
offered (ng); amount of f32m adsorbed (ng); equilibrium 132m
concentration (mg/liter); and percentage f32m adsorbed (%). The
last quantity was determined in the following manner:
amount 132m bound by membrane (ng)
amount (32m offered (ng) — amount 132m nonspecifically bound (ng)
x 100
600
0
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2
Equilibrium 135m concentration, mg/liter
Fig. 3. Equilibrium isotherm curves for (32m adsorption to both porous (fl)
and nonporous () PAN The porous curve is linear (r = 0.99). Values are
mean SEM; N = 4 or 5 for porous PAN and N = 3 or 4 for nonporous
PAN.
The percentage of offered 2m becoming membrane bound at
equilibrium was 15.2 2.0% (mean SEM).
The adsorption isotherm curves for porous and nonporous
PAN appear in Figure 3. The isotherm curves differ in two major
respects. First, for all equilibrium concentrations greater than 5
mg/liter, porous PAN bound more 132m than the nonporous PAN.
For example, at an equilibrium concentration of 42 mg/liter,
porous PAN adsorbed approximately eight times more 132m than
did the nonporous preparation (481 28 ng vs. 59 5 ng, P <
0.0005). This result confirmed that the overwhelming majority of
adsorptive sites for LMW proteins reside in the pore system and
that the contribution of the nominal surface area is minimal. The
other major difference between the two isotherm curves concerns
their shapes. As opposed to the porous isotherm, the nonporous
isotherm is nonlinear. However, logarithmic transformation of
both variables comprising the nonporous isotherm curve resulted
in a linear fit of these data also (Fig. 4). These features of the
nonporous PAN are consistent with a Freundlich isotherm, which
characterizes multilayer binding [30]. The observed f32m adsorbed
surface concentration (0.24 g/cm2) at the highest equilibrium
solution concentration was intermediate between the values pre-
dicted for monolayer side-on and end-on adsorption (0.17 and
0.39 pg/cm2, respectively). This suggests either snultilayer binding
of 2m strictly in a side-on orientation or adsorption of a
monolayer consisting of both types of orientations [29].
Adsorption kinetics
Kinetic data were derived directly from the binding curves (25
mg/liter) for both porous and nonporous PAN. Assessment of the
early stages of adsorption (that is, first 20 mm) allowed the
discernment of whether the initial rate of adsorption was con-
trolled by diffusion (mass transfer) to the membrane adsorption
site or by the intrinsic adsorption kinetics. Crank [31} has dem-
onstrated that in a diffusion-controlled adsorption process, the
fractional approach to equilibrium (amount adsorbed at time
Log equilibrium 2m concentration, mg/liter
Fig. 4. Logarithmic transformation of equilibrium data from Figure 3 for
nonporous PAN, resulting in a linear (Freundlich) isotherm (r = 0.99).
Values are mean; N = 3 or 4.
0.4
0.0
Time1t2 [(mm)1"2]
Fig. S. Kinetic data for f32m adsorption to porous (LI) and nonporous (•)
PANfrom an initial solution concentration of 25 mg/liter. The approach to
equilibrium is expressed as Mt/Meq, where M and Meq are the amounts
bound at time t and at equilibrium, respectively. For both curves, a linear
relationship is present (r = 0.99 for both). Values are mean SEM; N =
4 for porous PAN and N = 3 or 4 for nonporous PAN.
t/amount adsorbed at equilibrium) is related to the square root of
time [(time)112] in a linear manner. Figure 5 shows /32m adsorption
to both porous and nonporous PAN was mass transfer-limited. In
addition, that the approach to equilibrium was less steep (slower)
for the porous than the nonporous PAN is explained by two
properties of the porous PAN. First, adsorption to the porous
PAN involved two diffusional steps (film and pore diffusion) while
only film diffusion pertained to nonporous PAN. Second, the
greater number of binding sites on the porous PAN resulted in a
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Adsorption residence time, minutes
Fig. 6. Desorption of J3in from porous PAN as a function of adsorption
residence time. The amount of $32m remaining adsorbed after both fi2m
solution and buffer incubations is expressed relative to the amount bound
during incubation in f32m solution alone without subsequent buffer
incubation. The fractions remaining bound for adsorption residence times
of 60, 120, and 240 minutes were significantly different from the value at
5 minutes. *D C 0.005; ** C 0.0005. Values are mean saM; N = 4.
relatively less rapid occupation of these sites during the approach
to equilibrium.
J32m adsorption reversibility
2m desorption from porous PAN as a function of adsorption
residence time is depicted in Figure 6. The fraction f32m remain-
ing bound after buffer incubation is the ratio of the membrane-
associated radioactivity of the test membrane to that of the
control membrane for each adsorption time, Compared to the
value for an adsorption residence time of five minutes (0.23
0.01), the fractions remaining bound at 60, 120, and 240 minutes
(0.34 0.02, 0.36 0.06, and 0.44 0.03, respectively) were
significantly greater. The results are consistent with the enhance-
ment of protein-membrane adsorptive forces during prolonged
residence times, probably due to 132m conformational changes
induced by denaturation.
Discussion
The exposure of blood to any artificial surface results in the
nearly instantaneous deposition of a layer of plasma proteins [32].
The composition of the adsorbed protein layer mediates the
thrombogenicity [33] and biocompatibility [22, 24, 34] of any
biomaterial, porous or nonporous. Two additional features of
plasma protein adsorption apply specifically to porous materials.
First, the adsorbed protein layer may significantly influence both
the diffusional and convective transport characteristics of an
extracorporeal membrane [35]. In addition, adsorption is a mech-
anism by which proteins, especially those in the LMW class, are
removed appreciably from the plasma by an extracorporeal ther-
apy [10—18, 22—24].
Prior to the actual binding of a protein by a surface, mass
transfer to the adsorptive site must occur. For a nonporous
* * biomaterial, mass transfer involves diffusion (and possibly convec-
tion) of the protein through the ifim (boundary) layer adjacent to
the surface [27]. The thickness of this film layer, which is directly
proportional to mass transfer resistance, is determined by the
dialyzer operating conditions, such as blood flow rate, tempera-
ture, and geometry [36]. The pore system of a membrane repre-
sents an additional resistance to mass transfer for proteins whose
molecular dimensions allow pore entry.
Assessment of the rate of mass transfer to a binding site is a
requisite part of the analysis of any protein adsorption process.
Inspection of kinetic data permits the determination of the
rate-limiting step (RLS) to be either mass transfer or intrinsic
adsorption kinetics. The design of a membrane-based adsorption
system, such as hemodialysis or hemofiltration, with optimized
/32m removal capability, requires knowledge of this RLS. In a
mass transfer-limited system, increases in the blood flow rate or
transmembrane pressure, by their effect on the rates of film
diffusion and pore convection, respectively, also increase the
overall rate of /32m membrane adsorption. However, these
changes in dialyzer operating conditions do not significantly alter
the overall rate of adsorption of a system limited by slow intrinsic
adsorption. Previous studies have not rigorously assessed the
kinetics of /32m membrane adsorption in this manner.
The kinetic analysis of 2m adsorption to the PAN membrane
in our experimental system demonstrated that the initial RLS was
diffusion. We investigated the relationship between the approach
to adsorption equilibrium and (time)"2, as suggested by Crank in
his analysis of adsorption to a planar sheet [31]. Diffusion control
was shown by the linearity of this relationship for both the porous
and nonporous PAN preparations.
An adsorption isotherm represents the equilibrium relationship
between the surface and solution phases of a protein at a constant
temperature and permits determination of both the affinity and
capacity of a biomaterial for that protein [27, 30]. In the evalua-
tion of hemodialyzers, these isotherm data can be used to
compare quantitatively the adsorption of a certain protein to a
variety of artificial membranes. A Langmuir isotherm is charac-
terized by a linear relationship between the solid and solution
phases at low values of the latter. At higher solution phase
concentrations, the solid phase concentration reaches a plateau,
corresponding to monolayer protein deposition [30]. The slope of
the initial linear portion is proportional to adsorption affinity
while the plateau surface concentration represents the capacity. In
prior single-component studies, the isotherms for plasma protein
adsorption onto both nonporous biomaterials and extracorporeal
membranes have generally been reported to be of the Langmuir
type [37—40]. However, exceptions to this general rule have been
described. Schmitt et al [41] found a Freundlich isotherm, consis-
tent with multilayer binding, more accurately described equilib-
rium adsorption of fibrinogen to nonporous surfaces than did a
Langmuir isotherm. Prior investigations of j32m membrane ad-
sorption have not included isotherm analyses.
Our isotherm studies assessed the equilibrium adsorption of
j32m to both porous and nonporous PAN. Over a solution
concentration range applicable to patients with end-stage renal
disease [42], the isotherm curve for the porous PAN was linear.
For the nonporous isotherm curve, logarithmic transformation of
both variables resulted in a linear fit of these data also. This is
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characteristic of a Freundlich isotherm. The value of our experi-
mentally determined 2m adsorbed surface concentration ex-
ceeded that predicted for side-on monolayer deposition and suggests
j32m binding to nonporous PAN was multilayer. However, a mono-
layer consisting of j32m adsorbed in both side-on and end-on
orientations is an alternative explanation for this finding. The com-
parative isotherm studies also demonstrated that, for a LMW protein
capable of entry into the PAN pore structure, adsorption occurs
predominantly there as opposed to the nominal surface area.
A large body of evidence suggests that adsorbed proteins are
structurally modified while residing on an artificial surface [29,
43—53]. Soderquist and Walton [29] have characterized protein
adsorption as a three-stage process. The first stage is a brief
period during which the process is totally reversible. This is
followed by a second phase in which adsorbed proteins, based on
adsorption (residence) time, undergo slow conformational
changes. During this phase, these conformational changes may
convert an initially reversibly bound protein to one that is
irreversibly adsorbed. The final stage consists of an adsorbed
protein population that is largely unfolded (denatured) and,
therefore, very unlikely to desorb. Detergent elution methods
[50—53] have been utilized to provide indirect evidence of this
phenomenon. These studies have generally demonstrated, with
increasing adsorption residence time, that elution of an adsorbed
protein with an agent such as sodium dodecyl sulfate (SDS)
becomes progressively more difficult. The purported mechanism
for this observation is the unfolding of the adsorbed protein from
its native state, with exposure of interior hydrophobic amino acid
residues to a hydrophobic adsorbing surface. This denaturation
process may also enhance protein-protein interactions (aggrega-
tion), resulting in multilayer binding [54]. Our equilibrium iso-
therm studies suggest that denaturation of adsorbed f32m may
have occurred.
We specifically investigated 2m denaturation with adsorption
reversibility experiments. As performed by other investigators
[50—53], the extent of 2m desorption versus adsorption residence
time was used as an indirect measure of denaturation. These
studies provided additional evidence of 2m conformational
changes induced by prolonged contact with a hydrophobic extra-
corporeal membrane. The clinical implications of these mem-
brane-induced changes in !32m structure are presently unclear.
Increased treatment time may increase f32m adsorptive removal
by two mechanisms. First, 132m denaturation with increasing
treatment time results in an increasing percentage of 2m mole-
cules that is irreversibly bound. In addition, the denaturation
process may promote the development of multilayer binding.
However, the desorption of any denatured J32m into the blood
may be deleterious in two respects. First, desorbed $32m may not
reacquire its native state in the blood but rather may return to the
patient in an "activated" state [43]. That f32m conformational
changes induced in this manner may promote subsequent f32m
polymerization and amyloid deposition is a possibility that re-
quires further investigation. Second, denaturation appears to
impair markedly the ability of a desorbed protein to readsorb [29].
Because denaturation alters protein molecular dimensions, J32m
transmembrane mass transfer may also be reduced. This possibil-
ity also merits further examination.
The limitations of this study mainly concern the differences
between the operating conditions of our experiments and those of
clinical hemodialysis. Our experimental design utilized a static
configuration as opposed to hemodialysis, in which axial flow of
blood exists. The change from static to flow conditions reduces the
thickness of the film layer adjacent to a surface [36]. This change
is expected to have little effect on adsorption equilibrium but may
alter adsorption kinetics. If film diffusion was the RLS in our
experimental system, the presence of axial flow may have reduced
the film layer resistance to the extent that either pore diffusion or
even intrinsic adsorption kinetics became the RLS. Future exper-
iments incorporating flow will be required to assess this possibility.
The other major limitation of our study was the nature of the /32m
solution, which contained neither additional proteins nor cellular
elements. However, these single-component studies will serve as a
reference for subsequent similar studies which more closely
approximate clinical hemodialysis. These future studies will need
to involve multicomponent protein solutions, both buffer-based
and plasma, and blood.
In summary, DRA currently affects a significant proportion of
patients receiving chronic hemodialysis worldwide. Since preven-
tion of this disorder must be the goal, the optimization of f32m
removal capabilities by present extracorporeal therapies is indi-
cated. In this study, the fundamental aspects of one removal
mechanism, membrane adsorption, were explored. Our novel
experimental and analytical approach suggests 132m adsorption to
sulfonated PAN results in denaturation, the extent of which is
proportional to adsorption residence time. This study also dem-
onstrates that f32m binding to this membrane is diffusion-limited
under static experimental conditions. With this investigation, we
hope to have laid the groundwork for comparison of PAN
adsorptive properties to those of other membrane-based and
nonmembrane-based therapies. In this manner, we hope to con-
tribute to the development of extracorporeal therapies capable of
preventing DRA.
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